Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Vizioli, Maria Grazia"" wg kryterium: Autor


Wyświetlanie 1-6 z 6
Tytuł :
Mitochondria-to-nucleus retrograde signaling drives formation of cytoplasmic chromatin and inflammation in senescence.
Autorzy :
Vizioli MG; Cancer Research UK Beatson Institute, Glasgow G61 1BD, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom.; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts 02138, USA.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Liu T; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, USA.
Miller KN; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, USA.
Robertson NA; Cancer Research UK Beatson Institute, Glasgow G61 1BD, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom.
Gilroy K; Cancer Research UK Beatson Institute, Glasgow G61 1BD, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom.
Lagnado AB; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55905, USA.; Institute for Cell and Molecular Biosciences, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne NE4 5PL, United Kingdom.
Perez-Garcia A; Cancer Research UK Beatson Institute, Glasgow G61 1BD, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom.
Kiourtis C; Cancer Research UK Beatson Institute, Glasgow G61 1BD, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom.
Dasgupta N; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, USA.
Lei X; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, USA.
Kruger PJ; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55905, USA.
Nixon C; Cancer Research UK Beatson Institute, Glasgow G61 1BD, United Kingdom.
Clark W; Cancer Research UK Beatson Institute, Glasgow G61 1BD, United Kingdom.
Jurk D; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55905, USA.; Institute for Cell and Molecular Biosciences, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne NE4 5PL, United Kingdom.
Bird TG; Cancer Research UK Beatson Institute, Glasgow G61 1BD, United Kingdom.; MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh EH1 64TJ, United Kingdom.
Passos JF; Department of Physiology and Biomedical Engineering, Mayo Clinic, Rochester, Minnesota 55905, USA.; Institute for Cell and Molecular Biosciences, Newcastle University Institute for Ageing, Newcastle University, Newcastle upon Tyne NE4 5PL, United Kingdom.
Berger SL; Epigenetics Institute, Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Dou Z; Center for Regenerative Medicine, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.; Harvard Stem Cell Institute, Harvard University, Cambridge, Massachusetts 02138, USA.; Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts 02114, USA.
Adams PD; Cancer Research UK Beatson Institute, Glasgow G61 1BD, United Kingdom.; Institute of Cancer Sciences, University of Glasgow, Glasgow G61 1QH, United Kingdom.; Sanford Burnham Prebys Medical Discovery Institute, La Jolla, California 92037, USA.
Pokaż więcej
Źródło :
Genes & development [Genes Dev] 2020 Mar 01; Vol. 34 (5-6), pp. 428-445. Date of Electronic Publication: 2020 Jan 30.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Signal Transduction*
Cell Nucleus/*pathology
Cellular Senescence/*physiology
Chromatin/*pathology
Cytoplasm/*pathology
Mitochondria/*pathology
Animals ; Cell Nucleus/physiology ; Gene Expression Regulation, Developmental/drug effects ; Histone Deacetylase Inhibitors/pharmacology ; Humans ; Inflammation/physiopathology ; MAP Kinase Signaling System/physiology ; Male ; Mice ; Mice, Inbred C57BL ; Mitochondria/drug effects ; Mitochondria/physiology ; Reactive Oxygen Species/metabolism ; Tumor Suppressor p53-Binding Protein 1/metabolism
Czasopismo naukowe
Tytuł :
Senescent thyrocytes and thyroid tumor cells induce M2-like macrophage polarization of human monocytes via a PGE2-dependent mechanism.
Autorzy :
Mazzoni M; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy.
Mauro G; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy.
Erreni M; Department of Immunology, IRCCS Humanitas Clinical and Research Center, Via Manzoni, 56, 20089, Rozzano, Milan, Italy. .
Romeo P; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy.
Minna E; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy.
Vizioli MG; Beatson Institute for Cancer Research, Bearsden, Glasgow, UK.; Institute of Cancer Sciences College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, G61 1BD, UK.
Belgiovine C; Department of Immunology, IRCCS Humanitas Clinical and Research Center, Via Manzoni, 56, 20089, Rozzano, Milan, Italy.
Rizzetti MG; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy.
Pagliardini S; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy.
Avigni R; Department of Immunology, IRCCS Humanitas Clinical and Research Center, Via Manzoni, 56, 20089, Rozzano, Milan, Italy.
Anania MC; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy.
Allavena P; Department of Immunology, IRCCS Humanitas Clinical and Research Center, Via Manzoni, 56, 20089, Rozzano, Milan, Italy.
Borrello MG; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy.
Greco A; Molecular Mechanisms Unit, Department of Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Via G.A. Amadeo, 42, 20133, Milan, Italy. .
Pokaż więcej
Źródło :
Journal of experimental & clinical cancer research : CR [J Exp Clin Cancer Res] 2019 May 21; Vol. 38 (1), pp. 208. Date of Electronic Publication: 2019 May 21.
Typ publikacji :
Journal Article
MeSH Terms :
Cellular Senescence/*drug effects
Cyclooxygenase 2/*genetics
Inflammation/*drug therapy
Thyroid Neoplasms/*drug therapy
Cell Differentiation/drug effects ; Cell Line, Tumor ; Cell Polarity/drug effects ; Cellular Senescence/genetics ; Chemokine CCL17/genetics ; Culture Media, Conditioned/chemistry ; Culture Media, Conditioned/pharmacology ; Cyclooxygenase 2 Inhibitors/pharmacology ; Flow Cytometry ; Gene Expression Regulation, Neoplastic ; Humans ; Inflammation/genetics ; Inflammation/pathology ; Macrophages/drug effects ; Macrophages/pathology ; Monocytes/drug effects ; Signal Transduction/drug effects ; Thyroid Epithelial Cells/drug effects ; Thyroid Epithelial Cells/pathology ; Thyroid Gland/drug effects ; Thyroid Gland/pathology ; Thyroid Neoplasms/genetics ; Thyroid Neoplasms/pathology
Czasopismo naukowe
Tytuł :
Cytoplasmic chromatin triggers inflammation in senescence and cancer.
Autorzy :
Dou Z; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Ghosh K; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Vizioli MG; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, UK.; Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1BD, UK.
Zhu J; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Sen P; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Wangensteen KJ; Department of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Simithy J; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Lan Y; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Lin Y; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Zhou Z; Biodynamic Optical Imaging Center (BIOPIC), Beijing Advanced Innovation Center for Genomics (ICG), School of Life Sciences, Peking University, Beijing 100871, China.
Capell BC; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Xu C; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Xu M; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Kieckhaefer JE; Department of Genetics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Center for Molecular Studies in Digestive and Liver Diseases, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Jiang T; Abramson Cancer Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Shoshkes-Carmel M; Department of Genetics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Center for Molecular Studies in Digestive and Liver Diseases, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Tanim KMAA; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Barber GN; Department of Cell Biology and the Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami, Florida 33136, USA.
Seykora JT; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Millar SE; Department of Dermatology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Kaestner KH; Department of Genetics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Center for Molecular Studies in Digestive and Liver Diseases, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Garcia BA; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Penn Epigenetics Institute, Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Adams PD; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, UK.; Institute of Cancer Sciences, College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow G61 1BD, UK.; Sanford Burnham Prebys Medical Discovery Institute, 10901 North Torrey Pines Road, La Jolla, California 92037, USA.
Berger SL; Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Department of Genetics, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Penn Epigenetics Institute, Department of Cell and Developmental Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.; Department of Biology, School of Arts and Sciences, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA.
Pokaż więcej
Źródło :
Nature [Nature] 2017 Oct 19; Vol. 550 (7676), pp. 402-406. Date of Electronic Publication: 2017 Oct 04.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Immunity, Innate*
Cellular Senescence/*genetics
Chromatin/*metabolism
Cytoplasm/*genetics
Inflammation/*genetics
Inflammation/*pathology
Neoplasms/*genetics
Neoplasms/*immunology
Animals ; Cell Line, Tumor ; Chromatin/immunology ; Cytokines/immunology ; Cytokines/metabolism ; Cytoplasm/immunology ; Female ; Humans ; Inflammation/immunology ; Liver/metabolism ; Male ; Membrane Proteins/deficiency ; Membrane Proteins/genetics ; Membrane Proteins/metabolism ; Mice ; Neoplasms/pathology ; Nucleotidyltransferases/metabolism ; Oncogene Protein p21(ras)/genetics ; Oncogene Protein p21(ras)/immunology ; Radiation, Ionizing
Czasopismo naukowe
Tytuł :
Senescence Can Be BETter without the SASP?
Autorzy :
Vizioli MG; Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom. Institute of Cancer Sciences College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom.
Adams PD; Beatson Institute for Cancer Research, Bearsden, Glasgow, United Kingdom. Institute of Cancer Sciences College of Medical, Veterinary and Life Sciences, University of Glasgow, Glasgow, United Kingdom. .
Pokaż więcej
Źródło :
Cancer discovery [Cancer Discov] 2016 Jun; Vol. 6 (6), pp. 576-8.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Comment
MeSH Terms :
Phenotype*
Cellular Senescence/*genetics
Chromatin ; Humans
Czasopismo naukowe
Tytuł :
HIRA orchestrates a dynamic chromatin landscape in senescence and is required for suppression of neoplasia.
Autorzy :
Rai TS; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom; Institute of Biomedical and Environmental Health Research, University of West of Scotland, Paisley PA1 2BE, United Kingdom .
Cole JJ; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom;
Nelson DM; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom;
Dikovskaya D; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom;
Faller WJ; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom;
Vizioli MG; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom;
Hewitt RN; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom;
Anannya O; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom;
McBryan T; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom;
Manoharan I; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom;
van Tuyn J; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom;
Morrice N; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom;
Pchelintsev NA; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom;
Ivanov A; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom;
Brock C; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom;
Drotar ME; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom;
Nixon C; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom;
Clark W; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom;
Sansom OJ; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom;
Anderson KI; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom;
King A; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom;
Blyth K; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom;
Adams PD; Beatson Institute for Cancer Research, Bearsden, Glasgow G61 1BD, United Kingdom; Institute of Cancer Sciences, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow G61 1BD, United Kingdom; .
Pokaż więcej
Źródło :
Genes & development [Genes Dev] 2014 Dec 15; Vol. 28 (24), pp. 2712-25.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
MeSH Terms :
Cell Cycle Proteins/*metabolism
Cellular Senescence/*physiology
Histone Chaperones/*metabolism
Transcription Factors/*metabolism
Animals ; Antineoplastic Agents, Hormonal/pharmacology ; Carcinogenesis/drug effects ; Carcinogenesis/genetics ; Cell Cycle Proteins/genetics ; Cell Line ; Cell Proliferation ; Cellular Senescence/genetics ; Chromatin/metabolism ; Female ; Gene Expression Regulation/drug effects ; Genetic Markers ; Histone Chaperones/genetics ; Histones/genetics ; Histones/metabolism ; Humans ; Male ; Mice ; Papilloma/pathology ; Skin Neoplasms/pathology ; Tamoxifen/pharmacology ; Transcription Factors/genetics
Czasopismo naukowe
    Wyświetlanie 1-6 z 6

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies